InvestorsHub Logo

RainmanOregon

09/21/11 2:43 PM

#341 RE: MissionIR #340

Hey Mission, can you sticky a few of those please?

Hedge Starz

09/22/11 9:24 AM

#344 RE: MissionIR #340

September 14, 2011
VistaGen Therapeutics Provides Investor Update On Corporate Activities and Upcoming Initiatives
May 17, 2011
VistaGen Therapeutics and Excaliber Enterprises Announce Completion of Reverse Merger and $3.8 Million Financing
January 12, 2011
VistaGen Therapeutics and NuPotential Receives NIH Grant to Develop Safer Approaches for Producing Patient-specific Induced Pluripotent Stem Cells
December 22, 2010
VistaGen Therapeutics Announces Successful Completion of Initial Phase 1 Safety Study of AV-101 for Neuropathic Pain
August 20, 2009
VistaGen Appoints Industry Veteran Shawn Singh as Chief Executive Officer
January 15, 2009
VistaGen and Capsant Sign Strategic Stem Cell Technology Commercialization Agreement
December 18, 2008
VistaGen and WARF Sign License Agreement for Human Embryonic Stem Cell Technology
December 16, 2008
VistaGen Receives Significant Stem Cell Tools and Technologies Grant from California Institute for Regenerative Medicine
October 16, 2008
VistaGen Team Pinpoints Key Biochemical Pathways Involved in Generating ES cell-derived Heart Cells